Celldex Therapeutics, Inc. Message Board
-
All the big volume occurred at the open.
Maybe some small fry selling, but odds are the big boys are scaling out of this, because market opens and closes are when they do business. -
ACAS?
If so then I will wait to buy at .60 -
Why is yahoo showing the book at half what it was a few weeks ago, or is my memory failing me?
-
How much is the current book value and how much are they holding over?
-
Rick, nothing wrong with buying at 7.75,. In fact I bought 1k at that price myself.
But why so many shares all at one price? -
Just when you thought you had it figured out. Poof!
Buy another 8k shares. -
So, what is the book now?
-
With that 5 dollar price target they put on this it will.
-
IntelGenx Technologies Corp., a drug delivery company, engages in the development of novel oral immediate-release and controlled-release products for the pharmaceutical market. Its product portfolio comprises INT0001/2004 for coronary heart failure and hypertension; INT0004/2006, an antidepressant; INT0007/2006 for the treatment of erectile dysfunction; INT0008/2007 for the treatment of migraine; INT0020/2010 for the treatment of insomnia; INT0024/2010 for idiopathic pulmonary fibrosis; INT0028/2011 for cancer pain; INT0030/2011 for animal health; and INT0031/2012 for the treatment of benign prostatic hyperplasia, as well as INT0027/2011, an oral controlled-release film product. The company develops its products based on three delivery platform technologies, which consist of the Multilayer Tablet technology that allows for the development of oral controlled-release products; the Oral Film technology, which allows for the delivery of pharmaceuticals to the oral cavity; and the Mucoadhesive Tablet technology for the controlled release of active substances to the oral mucosa. It also provides product development services for the pharmaceutical industry, including the branded and generic pharmaceutical markets. The company has a strategic alliance with LTS Lohmann Therapie-Systeme AG to manufacture pharmaceutical products using VersaFilm drug delivery technology. IntelGenx Technologies Corp. also has a co-development and commercialization agreement with RedHill Biopharma Ltd. for the co-development and commercialization of INT0008/2007. IntelGenx Technologies Corp. was founded in 2003 and is based in Ville Saint Laurent, Canada.
All this with ten full time employees??? - Reply to
Wopping 22% improvement in FY2013 EPS, jumps from -1.12 to -0.87, RIGL ready to explode
by delphioracle2009 •May 12, 2013 10:28 PMWhat I want to see is positive earnings, not caring much about negative improvements.
When will that happen?
It's about as hard getting excited about this as it is about the budget deficit. -
Since I've been in this the only thing I have seen create price appreciation is the earnings expectations run up of the past week or two.
That is over for now and I would feel lucky if this worked up to 8.
But it's ok to have a positive mental attitude about this, so I won't call you guys pumpers. - Reply to
Why no press release or Conference call today? Does this company give a hoot about their
by jabberjawone •May 16, 2013 10:56 PMThink Goldman Sacks and you will understand the mentality of those in the financial business.
-
And why should we believe this is any more than a wild guess?
-
And is the recent run up also option related.
-
Stocks look forward.
That's why so much weight is put on forward guidance.
There was no reason to believe earnings would improve as of the first qtr. of last year so the stock did not move until it became apparent that the years earnings would exceed expectations.
What was book value last year?
Take a look at LNKD with a 1000 pe. -
Yes! It looks like just another case of buy the rumor and sell the news.
If there was allot of big money backing this stock you might see a nice bounce back as the sellers shares are bought up by inst.
But with this stock having such low demand from big players it's hard to see if we get much buying. -
I still think it's profit taking, but I'm no expert.
-
My gut tells me not to, but I did it anyway.
Bought 500 at 7.20 -
paste it.
-
I suspect profit taking.
Buy the rumor sell the news.
But an 85% increase in mtge. earnings looks good to me.